polycystic ovarian syndrome. E28.2
Conditions
Interventions
Intervention 1: Control group- placebo-ORS- 3 per day for 6 week. Intervention 2: Metformin group- 1500 mg/ day -6 week. Intervention 3: NAC group- 1800 mg/day - 6 week.
Placebo
Treatment - Drugs
Control group- placebo-ORS- 3 per day for 6 week
Metformin group- 1500 mg/ day -6 week
NAC group- 1800 mg/day - 6 week
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
25 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion critria: age between 25 to 35 years old and PCOS diagnosed according to Rotterdam criteria (2003). Exclusion criteria: presence of infertility factors other than anovulation,male infertility; pelvic organic pathologies; congenital adrenal hyperplasia; thyroid dysfunction; Cushing’s syndrome; hyperprolactinemia; androgen secreting neoplasia; diabetes mellitus; severe hepatic or kidney diseases and active peptic ulcer.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biochemical factors of follicular fluid. Timepoint: After 2 month. Method of measurement: Lab. kits.;Oocyte and embryo quality. Timepoint: After 2 month. Method of measurement: Morphology.;Biochemical factors of blood serum. Timepoint: After 2 month. Method of measurement: Lab. kits. | — |
Secondary
| Measure | Time frame |
|---|---|
| Gastation rate. Timepoint: After 3 month. Method of measurement: Lab. kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr, Marzie Aavi Soltani
Qom ACECR Infertility Treatment Highly Specialized Center
Outcome results
None listed